MERCK KGAA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 157.5 EUR | -5.72% |
|
-6.89% | +9.30% |
| 25/06 | German Stocks Fall Tuesday | DJ |
| 25/06 | Market Update-Europe closes lower in a session marked by a wait-and-see attitude | RE |
Presenter SpeechWolfgang Büchele (Executives)Ladies and gentlemen, shareholders, on behalf of ...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows:
- solutions and products for scientific and biotechnological research (44.2%);
- pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;
- performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc.
Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
Pharmaceuticals
Calendar
01/08/2024
- Q2 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
157.5
EUR
Average target price
184.4
EUR
Spread / Average Target
+17.10%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +9.30% | 77.92B | |
| +17.13% | 8.95B | |
| -24.00% | 4.31B | |
| +13.37% | 4.21B | |
| +31.17% | 4.1B | |
| +6.41% | 2.21B | |
| -34.04% | 1.96B | |
| +7.56% | 1.95B | |
| -0.50% | 1.64B | |
| -47.93% | 1.62B |
- Stock Market
- Equities
- MRK Stock
- News Merck KGaA
- Transcript : MERCK Kommanditgesellschaft auf Aktien - Shareholder/Analyst Call
